- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04244617
Peer-supported Internet Mediated Psychological Treatment
Peer-supported Internet Mediated Psychological Treatment for Adults With Anxiety Disorders in Primary Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is a mixed methods design consisting of an un-controlled pragmatic effectiveness study combined with semi-structured interviews in order to investigate the participant´s experience of treatment. Participants were recruited from patients who were referred to a central unit for internet- CBT (Cognitive Behavioral therapy) in primary care in Västra Götaland region, Sweden. Peer-supporters were recruited through a swedish patient organization. Participants were adults 18 years of age or older with an anxiety disorder.
All participants were interviewed by a psychologist with a diagnostic instrument, a structured interview called PRIME-MD, before starting treatment. After the interview, all patients who were offered iCBT and met the inclusion criteria were requested to participate in the study.
Patients who accepted inclusion were guided by both a psychologist and a peer-support in the iCBT treatment used in the study. The iCBT treatment program used is a transdiagnostic program aimed at treating people with mild to moderate anxiety problems.
Quantitative data about psychosocial symptoms were collected, and qualitative data about the participants experience of treatment were collected through semi-structured interviews.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Västra Götaland Region
-
Borås, Västra Götaland Region, Sweden
- Närhälsan, Primary care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- participants must have reached the age of 18
- have access to a computer with internet Connection
- speak and understand Swedish
- meet the diagnostic criteria for an anxiety disorder (social anxiety, GAD, panic disorder, obsessive-compulsive disorder, or unspecified anxiety disorder).
Exclusion Criteria:
- have started medication or have made major changes regarding their medication in the past few months
- have serious suicidal ideation or suicide plans
- are expected to have complex problems or be in need of other care
- are under any other psychological treatment during the time of the treatment period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: iCBT with addition of peer-support (iCBT-PS)
Participants in the iCBT-PS, are guided by both a psychologist and a peer-support in the iCBT-program used in the study.
|
Peer-supporters and participants, as well as psychologists and participants, interact in the treatment program via asynchronous secure messages.
Peer-supporters are able to give support and feedback on exercises.
A reconciliation call via telephone is entered into the middle of the treatment and a follow-up call after completion of treatment conducted by the peer-support.
The interaction between peer-supporters and participants is tracked by the psychologist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Anxiety symptoms
Time Frame: Baseline (Pre-treatment), post treatment (after 8 weeks) and by 3 month follow up
|
Anxiety is measured with the GAD-7 instrument (Generalized Anxiety Disorder 7 item scale).
The scale consists of 7 items.
The score ranges from 0 to 21, with higher scores indicating more anxiety symptoms.
There are thresholds for mild, medium and severe anxiety (Spitzer, Kroenke, Williams & Löwe 2006).
|
Baseline (Pre-treatment), post treatment (after 8 weeks) and by 3 month follow up
|
|
Change in Depressive symptoms
Time Frame: Baseline (Pre-treatment), post treatment (after 8 weeks) and by 3 month follow up
|
Symptoms of depression is measured with Madrs-s (Montgomery Åsberg Depression Rating Scale; Montgomery & Åsberg, 1979).
The instrument consists of 9 items.
Scores ranges from 0 to 60, with higher scores indicating more depressive symptoms.
There are cut-off points for symptom severity.
|
Baseline (Pre-treatment), post treatment (after 8 weeks) and by 3 month follow up
|
|
Change in symptoms of psychological distress
Time Frame: Baseline (Pre-treatment) and post treatment (after 8 weeks) (Since this instrument is provided in connection with the modules in the treatment program
|
Symptoms of psychological distress is measured with the CORE-10 (Barkham et al., 2012).
Score ranges from 0 to 40, with higher scores indicating more psychological distress.
The instrument consists of 10 items and has clinical cut-off scores for general psychological distress.
|
Baseline (Pre-treatment) and post treatment (after 8 weeks) (Since this instrument is provided in connection with the modules in the treatment program
|
|
Changes in feelings of empowerment
Time Frame: Baseline (Pre-treatment), post treatment (after 8 weeks) and by 3 month follow up
|
Empowerment is measured with the Empowerment Scale (Rogers, Chamberlin, Ellison & Crean, 1997).
The scale consists of 28 items which are answered on a four-point likert scale.
Score ranges between 28 and 112.
Higher scores indicates that the person feels more empowered.
|
Baseline (Pre-treatment), post treatment (after 8 weeks) and by 3 month follow up
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Sandra Weineland, PhD, Department of Psychology, University of Gothenburg, Sweden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Drn EPN: 845-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorder
-
Vincent AgyapongNova Scotia Health Authority; Dalhousie UniversityRecruitingGeneralized Anxiety Disorder | Major Depressive Disorder | Mental Health Wellness 1Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Brigham and Women's HospitalActive, not recruitingDepression | Mood Disorders | Depressive Disorder, Major | Psychiatric Disorder | Mental DisorderUnited States
-
Queen's UniversityCompleted
-
University of ManchesterRecruitingADHD | Mental Health | Autism | Neurodevelopment | Depression - Major Depressive Disorder | Anxiety Disorder (Panic Disorder or GAD)United Kingdom
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
Brigham and Women's HospitalActive, not recruitingDepression | PTSD | Mood Disorders | Anxiety Disorders | OCD | Major Depressive Disorder | Psychiatric Disorder | Mental DisorderUnited States
-
University of ChicagoUsona InstituteCompletedMajor Depressive Disorder | Borderline Personality DisorderUnited States
Clinical Trials on iCBT with addition of peer-support
-
Linkoeping UniversityCompleted
-
Northwestern UniversityCompletedDepressionUnited States
-
Universitätsklinikum Hamburg-EppendorfUniversity of UlmActive, not recruitingSevere Mental Health Condition With Indication of Hospital AdmissionGermany
-
Universiti Putra MalaysiaNot yet recruitingTreatment Adherence and CompliancePakistan
-
Karolinska InstitutetRegion StockholmActive, not recruiting
-
Yale UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingSubstance Use | Mental Health Issue | Financial HardshipUnited States
-
Johns Hopkins UniversityMU-JHU CARECompletedBreast Feeding | HIV-infection/Aids
-
Shanghai 6th People's HospitalUniversity of North Carolina, Chapel Hill; Merck FoundationCompletedPreDiabetes | Type2 DiabetesChina
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedPersonality Disorders | Depression | Schizophrenia | Anxiety Disorders | Bipolar Disorder | Cognitive DisordersUnited States
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting